Par Pharma Shareholders Seek Settlement Approval
Par shareholders are seeking approval for the settlement in a motion filed in the U.S. District Court for New Jersey. The agreement includes a $200,000 payment to the shareholders' lawyers.
The agreement comes days after a New Jersey district judge tossed a related consolidated class action suit against Par and four of its top executives....
To view the full article, register now.